Biomarker evaluation and validation are the key steps and remain the bottleneck in biomarker development processes. Prospect's EDGE*TEST relies on Edge technology and our proprietary algorithm to statistically differentiate between diseased and healthy, or control and treated, tissue and cell samples. EDGE*TEST using Edge 200 Separation System provides:

• a simple and reproducible technique for fractionation of tissue homogenates/cell lysates
• a unique statistical method for evaluation of potential biomarkers based on relative percent distribution of the marker
• the opportunity for generating data for further clinical validation

Benefits:

• DOES NOT require any internal or external standards
• Independent of sample amount
• Reproducible from lab to lab
• Rapid screening of biomarkers
• Applicable to any stage of development
• Time and cost effective